Greater attention to gastric premalignant conditions should help reduce the incidence of gastric cancer and increase the ...

Scientists have carefully examined somatic mutations in stomach lining tissue to uncover mutational mechanisms that can lead ...

A mother-of-four has been given months to live after she first mistook her difficulty swallowing for a side effect of a ...

截至到2025年3月11日，由Sam S Yoon作为负责人的已经被撤回包括在MOLECULAR CANCER RESEARCH，Cancer Research，CLINICAL CANCER RESEARCH 及Cell Death & ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.

The FDA has approved Keytruda plus chemotherapy in HER2+ gastric or GEJ adenocarcinoma with PD-L1–positive expression, based on KEYNOTE-811 data.

Stomach cancer symptoms can often be mistaken for less severe conditions, such as indigestion. One of the most common signs ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...